CDDO-compounds and combination therapies thereof
US7435755B2 · kind B2 · utility
90Cited by
5References
51Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 28, 2001 |
| Grant date | Oct 14, 2008 |
| Priority date | — |
| Expiry date | Jul 16, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
CDDO-compounds in combination with other chemotherapeutic agents induce and potentiate cytotoxicity and apoptosis in cancer cell. One class of chemotherapeutic agents include retinoids. Cancer therapies based on these combination therapies are provided. Also provided are methods to treat graft versus host diseases using the CDDO compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.